These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 1703920)

  • 21. [Effect of intravenous administration of nitroglycerin and regitine on hemodynamics in mitral valve insufficiency].
    Korewicki J; Rajecka A; Pogorzelska H; Madeja G
    Kardiol Pol; 1990; 33(6):365-74. PubMed ID: 2128094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ibopamine versus digoxin in the treatment of mild congestive heart failure. A double-blind, randomized, placebo-controlled trial.
    Kleber FX; Thyroff-Friesinger U
    Cardiology; 1990; 77 Suppl 5():75-80. PubMed ID: 2279256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevention of tolerance to hemodynamic effects of nitrates with concomitant use of hydralazine in patients with chronic heart failure.
    Gogia H; Mehra A; Parikh S; Raman M; Ajit-Uppal J; Johnson JV; Elkayam U
    J Am Coll Cardiol; 1995 Dec; 26(7):1575-80. PubMed ID: 7594088
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Ibopamine in the treatment of congestive heart failure. Multicenter follow-up study].
    Fonseca C; Gouveia R; Ceia F; Mota E; Coelho EM; Gil V; Riva E; Astorga MA; Gomes RS; Luís AS
    Rev Port Cardiol; 1992 Jun; 11(6):515-23. PubMed ID: 1503784
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hemodynamic evaluation of ibopamine in patients with refractory congestive heart failure.
    Humar F; Morgera T; Maras P; Camerini F
    Arzneimittelforschung; 1986 Feb; 36(2A):360-2. PubMed ID: 3707650
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemodynamic effects of ibopamine in patients with idiopathic congestive cardiomyopathy.
    Dei Cas L; Bolognesi R; Cucchini F; Fappani A; Riva S; Visioli O
    J Cardiovasc Pharmacol; 1983; 5(2):249-53. PubMed ID: 6188898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dopaminergic drugs in congestive heart failure: hemodynamic and neuroendocrine responses to ibopamine, dopamine, and dihydroergotoxine.
    Metra M; Missale C; Spano PF; Cas LD
    J Cardiovasc Pharmacol; 1995 May; 25(5):732-40. PubMed ID: 7630152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ibopamine in the treatment of mild chronic heart failure in elderly patients. A double-blind, placebo-controlled study.
    Azzolini A; Guffanti E; Ronzitti M; Tantalo L; Colantoni A; Pizzorni C
    Cardiology; 1990; 77 Suppl 5():89-95. PubMed ID: 2279258
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ibopamine in very severe congestive heart failure: pilot haemodynamic invasive assessment.
    Col J; Mievis E; Reynaert M
    Eur J Clin Pharmacol; 1983; 24(3):297-300. PubMed ID: 6861844
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Acute and chronic effects of a new oral inotropic agent, ibopamine hydrochloride, on hemodynamic and metabolic responses to ergometer exercise in patients with severe congestive heart failure].
    Morimoto Y; Kasai A; Nagano K; Umino M; Kakuta Y; Iwata J; Hamada M; Konishi T; Nakano T
    Kokyu To Junkan; 1989 Jul; 37(7):773-8. PubMed ID: 2799097
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of long-term therapy with oral ibopamine on resting hemodynamics and exercise capacity in patients with heart failure: relationship to the generation of N-methyldopamine and to plasma norepinephrine levels.
    Rajfer SI; Rossen JD; Douglas FL; Goldberg LI; Karrison T
    Circulation; 1986 Apr; 73(4):740-8. PubMed ID: 3948372
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of oral ibopamine in patients with mild heart failure--a double blind placebo controlled comparison to furosemide. The Ibopamine Study Group.
    Parker JO
    Int J Cardiol; 1993 Jul; 40(3):221-7. PubMed ID: 8225657
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute effects of ibopamine hydrochloride on hemodynamics, plasma catecholamine levels, renin activity, aldosterone, metabolism and blood gas in patients with severe congestive heart failure.
    Nakano T; Morimoto Y; Kakuta Y; Konishi T; Kodera T; Kanamaru M; Takezawa H
    Arzneimittelforschung; 1986 Dec; 36(12):1829-34. PubMed ID: 3551968
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hemodynamic effects of concomitant nitroglycerin ointment and nifedipine treatment in acute myocardial infarction.
    Mori K; Onoe T; Ohka T; Kanaya H
    Jpn Heart J; 1982 Sep; 23(5):739-47. PubMed ID: 6816955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative effects of ibopamine and captopril in mild congestive heart failure. Focus on the long-term effects of inodilation on ventricular arrhythmias.
    Cocchieri M; Alunni GF; Del Favero A; Fortunati F; Bardelli G; Capponi EA; Regi L; Boschetti E
    Cardiology; 1990; 77 Suppl 5():36-42. PubMed ID: 2126222
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Absence of proarrhythmic effects of ibopamine in patients with congestive heart failure.
    Caponnetto S; Terrachini V; Canale C; Bruzzone F; Licciardello L; Marchetti GV
    J Cardiovasc Pharmacol; 1989; 14 Suppl 8():S104-10. PubMed ID: 2483435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The safety profile of ibopamine, an alternative substance for treatment of chronic heart failure.
    Holubarsch C; Just H
    Cardiology; 1990; 77 Suppl 5():1-8. PubMed ID: 2279251
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of ibopamine in type II diabetic patients with mild chronic heart failure. A double-blind cross-over study.
    Marchetti P; Sabino F; Giannarelli R; DiCarlo A; Cicchetti V; Navalesi R
    Cardiology; 1990; 77 Suppl 5():57-62. PubMed ID: 2279253
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A randomized multicenter study comparing the efficacy and safety of intravenous milrinone and intravenous nitroglycerin in patients with advanced heart failure.
    Loh E; Elkayam U; Cody R; Bristow M; Jaski B; Colucci WS
    J Card Fail; 2001 Jun; 7(2):114-21. PubMed ID: 11420762
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety of ibopamine therapy in congestive heart failure. Ibopamine cohort study: baseline and 1-year results.
    Sher D; Licciardello L; Ferrari V; Sirtori F; Cesana B
    Arzneimittelforschung; 1991 Apr; 41(4):402-9. PubMed ID: 1859514
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.